NCT07291128 Effects of VOJTA Technique on Ataxic Cerebral Palsy.
| NCT ID | NCT07291128 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lahore University of Biological and Applied Sciences |
| Condition | Ataxic Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-12-08 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-12-08 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ataxic cerebral palsy (CP) is the least common subtype of CP and it is primarily caused by cerebellar damage that results in hypotonia, impaired balance, poor coordination, tremors, wide-based gait, and significant difficulties in trunk stability and uncontrolled movements. These impairments greatly affect functional mobility and independence in life. This randomized controlled trial aims to evaluate the effects of VOJTA therapy on muscle tone, gross motor function, and postural control in children with ataxic CP aged 2-6 years. VOJTA therapy is based on reflex locomotion, which activates innate central motor programs by stimulating specific pressure zones in defined positions, potentially improving postural alignment and coordinated muscle activation. A total of 40 children will be randomly assigned to either the VOJTA therapy group or a conventional physiotherapy group. Both groups will receive total of 5 sessions per week for 8 weeks and the Outcomes will be measured at baseline, 4 weeks, and 8 weeks using the Modified Ashworth Scale (MAS) for muscle tone, Gross Motor Function Measure (GMFM-88) for gross motor function and Pediatric balance scale for for balance. This study hypothesizes that VOJTA therapy will produce greater improvements in muscle tone, gross motor function and balance as compared to conventional physical therapy techniques. Findings may support evidence-based rehabilitation strategies for ataxic CP and contribute to improved functional independence and quality of life in this understudied population.
Eligibility Criteria
Inclusion Criteria: Both male and female participants would be included Children diagnosed with ataxic cerebral palsy. Age range of participants will be 2 to 6 years old. Participants included will be at level 2 on gross motor function classification scale. Participants included will have ATNR reflex. Stable medical condition for the past three months with no hospitalizations. Exclusion Criteria: Presence of severe comorbidities i.e. neurological or orthopedic conditions. Patients having significant cognitive deficits Down syndrome, hydrocephalus, epilepsy, autism and medically ill children Children with visual or auditory deficits affecting postural control and balance assessment. Ongoing pharmacological treatment (e.g., muscle relaxants or antiepileptic) likely to influence muscle tone or motor function during the study period
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07291128 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 6 Years, studying Ataxic Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07291128 currently recruiting?
Yes, NCT07291128 is actively recruiting participants. Contact the research team at Fareehaijaz2018@gmail.com for enrollment information.
Where is the NCT07291128 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07291128 clinical trial?
NCT07291128 is sponsored by Lahore University of Biological and Applied Sciences. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.